These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32336599)

  • 1. Human papillomavirus vaccine coverage in Rwanda: A population-level analysis by birth cohort.
    Sayinzoga F; Umulisa MC; Sibomana H; Tenet V; Baussano I; Clifford GM
    Vaccine; 2020 May; 38(24):4001-4005. PubMed ID: 32336599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys.
    Sayinzoga F; Tenet V; Heideman DAM; Sibomana H; Umulisa MC; Franceschi S; Hakizimana JD; Clifford GM; Baussano I
    Lancet Glob Health; 2023 Jul; 11(7):e1096-e1104. PubMed ID: 37207683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
    Garon J; Wuddhika IV; Sreenivasan N; Wannemuehler K; Vutthikol Y; Chhorvann C; Loharikar A
    Vaccine; 2019 Feb; 37(9):1202-1208. PubMed ID: 30686637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of a National HPV vaccination program into Bhutan.
    Dorji T; Tshomo U; Phuntsho S; Tamang TD; Tshokey T; Baussano I; Franceschi S; Clifford G
    Vaccine; 2015 Jul; 33(31):3726-30. PubMed ID: 26057136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination coverage rates and predictors of HPV vaccination among eligible and non-eligible female adolescents at the Brazilian HPV vaccination public program.
    Faisal-Cury A; Levy RB; Tourinho MF; Grangeiro A; Eluf-Neto J
    BMC Public Health; 2020 Apr; 20(1):458. PubMed ID: 32252705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage of HPV vaccination programme in Friuli Venezia Giulia Region (Northern Italy).
    Franceschi S; Gallo T; Panato C; Gongolo F; Franzo A
    Epidemiol Prev; 2020; 44(5-6):378-384. PubMed ID: 33706490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV vaccination coverage in three districts in Zimbabwe following national introduction of 0,12 month schedule among 10 to 14 year old girls.
    LaMontagne DS; Manangazira P; Marembo J; Chigodo C; Zvamashakwe C; Tshuma E; Marima E; Chindedza K; Ndlela E; Mooney J
    Vaccine; 2022 Mar; 40 Suppl 1():A58-A66. PubMed ID: 34275674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016.
    Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D
    Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study.
    Lim WT; Sears K; Smith LM; Liu G; Lévesque LE
    BMC Public Health; 2014 Oct; 14():1029. PubMed ID: 25278003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada.
    McClure CA; MacSwain MA; Morrison H; Sanford CJ
    Vaccine; 2015 Apr; 33(15):1786-90. PubMed ID: 25731789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misinformation Drives Low Human Papillomavirus Vaccination Coverage in South African Girls Attending Private Schools.
    Milondzo T; Meyer JC; Dochez C; Burnett RJ
    Front Public Health; 2021; 9():598625. PubMed ID: 33681125
    [No Abstract]   [Full Text] [Related]  

  • 13. The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval.
    Martín-Merino E; Llorente-García A; Castillo Cano B; Montero Corominas D; Huerta-Álvarez C
    Pharmaceut Med; 2019 Dec; 33(6):519-530. PubMed ID: 31933243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs.
    Elfström KM; Lazzarato F; Franceschi S; Dillner J; Baussano I
    J Infect Dis; 2016 Jan; 213(2):199-205. PubMed ID: 26142436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual immunisation coverage report 2021.
    Hull B; Hendry A; Dey A; Brotherton J; Macartney K; Beard F
    Commun Dis Intell (2018); 2023 Aug; 47():. PubMed ID: 37817316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine testing to monitor the impact of HPV vaccination in Bhutan and Rwanda.
    Franceschi S; Chantal Umulisa M; Tshomo U; Gheit T; Baussano I; Tenet V; Tshokey T; Gatera M; Ngabo F; Van Damme P; Snijders PJ; Tommasino M; Vorsters A; Clifford GM
    Int J Cancer; 2016 Aug; 139(3):518-26. PubMed ID: 26991686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18-26 year olds in the United States.
    Adjei Boakye E; Lew D; Muthukrishnan M; Tobo BB; Rohde RL; Varvares MA; Osazuwa-Peters N
    Hum Vaccin Immunother; 2018; 14(8):2016-2024. PubMed ID: 29708826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV vaccination coverage and course completion rates for Indigenous Australian adolescents, 2015.
    Brotherton JM; Winch KL; Chappell G; Banks C; Meijer D; Ennis S; Peterson K; Webby R; Whop LJ
    Med J Aust; 2019 Jul; 211(1):31-36. PubMed ID: 31179546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania.
    Quentin W; Terris-Prestholt F; Changalucha J; Soteli S; Edmunds WJ; Hutubessy R; Ross DA; Kapiga S; Hayes R; Watson-Jones D
    BMC Med; 2012 Nov; 10():137. PubMed ID: 23148516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achieving high and equitable coverage of adolescent HPV vaccine in Scotland.
    Sinka K; Kavanagh K; Gordon R; Love J; Potts A; Donaghy M; Robertson C
    J Epidemiol Community Health; 2014 Jan; 68(1):57-63. PubMed ID: 23986492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.